ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
NIH Grant Funds Cancer Prevention Vaccine Research
Friday, December 9, 2022
Submitted by
Source
Source Name: Weill Cornell Medicine News
Researchers have been awarded a grant to fund cancer vaccine research, including the development of an mRNA vaccine that would target precancerous lung lesions. Eventually, researchers hope to develop an mRNA vaccine that targets groups of shared antigens in people with lung cancer, along with personalized vaccines directed at the genetic structure of each lung cancer patient’s tumor.
Printer-friendly
